Guizhou Bailing Group Pharmaceutical Co Ltd (002424) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.090x

Based on the latest financial reports, Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a cash flow conversion efficiency ratio of 0.090x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥294.76 Million ≈ $43.13 Million USD) by net assets (CN¥3.28 Billion ≈ $480.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002424 net asset quality score to measure how much of total assets are equity-financed.

Guizhou Bailing Group Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Guizhou Bailing Group Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Guizhou Bailing Group Pharmaceutical Co 's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Guizhou Bailing Group Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guizhou Bailing Group Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Medartis Holding AG SW:MED	0.088x
Grindrod JSE:GND	0.030x
Harbin Gloria Pharmaceuticals SHE:002437	0.076x
Sedlmayr Grund und Immobilien AG F:SPB	N/A
Sichuan Crun Co Ltd SHE:002272	-0.006x
INVEX Controladora S.A.B. de C.V MX:INVEXA	0.423x
Summit TA:SMT	0.016x
Karelia Tobacco Company Inc AT:KARE	0.022x

Annual Cash Flow Conversion Efficiency for Guizhou Bailing Group Pharmaceutical Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Guizhou Bailing Group Pharmaceutical Co Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Guizhou Bailing Group Pharmaceutical Co market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.17 Billion ≈ $464.57 Million	CN¥748.72 Million ≈ $109.56 Million	0.236x	+8263.87%
2024-12-31	CN¥3.20 Billion ≈ $468.14 Million	CN¥9.02 Million ≈ $1.32 Million	0.003x	-92.09%
2023-12-31	CN¥3.53 Billion ≈ $516.15 Million	CN¥125.77 Million ≈ $18.40 Million	0.036x	-71.62%
2022-12-31	CN¥4.00 Billion ≈ $584.87 Million	CN¥502.15 Million ≈ $73.48 Million	0.126x	+53.13%
2021-12-31	CN¥3.96 Billion ≈ $579.50 Million	CN¥324.92 Million ≈ $47.55 Million	0.082x	+38.77%
2020-12-31	CN¥3.92 Billion ≈ $573.66 Million	CN¥231.78 Million ≈ $33.92 Million	0.059x	-47.68%
2019-12-31	CN¥4.14 Billion ≈ $605.25 Million	CN¥467.41 Million ≈ $68.40 Million	0.113x	+381.70%
2018-12-31	CN¥3.92 Billion ≈ $574.31 Million	CN¥-157.45 Million ≈ $-23.04 Million	-0.040x	-274.11%
2017-12-31	CN¥3.47 Billion ≈ $507.36 Million	CN¥79.88 Million ≈ $11.69 Million	0.023x	-84.86%
2016-12-31	CN¥3.07 Billion ≈ $448.56 Million	CN¥466.62 Million ≈ $68.28 Million	0.152x	-1.24%
2015-12-31	CN¥2.68 Billion ≈ $392.31 Million	CN¥413.23 Million ≈ $60.47 Million	0.154x	-8.57%
2014-12-31	CN¥2.35 Billion ≈ $343.57 Million	CN¥395.83 Million ≈ $57.92 Million	0.169x	+153.01%
2013-12-31	CN¥2.13 Billion ≈ $311.30 Million	CN¥141.76 Million ≈ $20.74 Million	0.067x	+597.39%
2012-12-31	CN¥2.04 Billion ≈ $298.89 Million	CN¥19.52 Million ≈ $2.86 Million	0.010x	-90.82%
2011-12-31	CN¥1.94 Billion ≈ $283.94 Million	CN¥201.90 Million ≈ $29.54 Million	0.104x	+142.93%
2010-12-31	CN¥1.85 Billion ≈ $270.28 Million	CN¥-447.68 Million ≈ $-65.51 Million	-0.242x	-172.42%
2009-12-31	CN¥374.42 Million ≈ $54.79 Million	CN¥125.31 Million ≈ $18.34 Million	0.335x	+317.54%
2008-12-31	CN¥262.75 Million ≈ $38.45 Million	CN¥-40.42 Million ≈ $-5.92 Million	-0.154x	+64.59%
2007-12-31	CN¥182.68 Million ≈ $26.73 Million	CN¥-79.37 Million ≈ $-11.61 Million	-0.434x	--

About Guizhou Bailing Group Pharmaceutical Co Ltd

SHE:002424 China Drug Manufacturers - Specialty & Generic

Market Cap

$938.71 Million

CN¥6.41 Billion CNY

Market Cap Rank

#9074 Global

#2205 in China

Share Price

CN¥4.59

Change (1 day)

-0.22%

52-Week Range

CN¥4.09 - CN¥6.29

All Time High

CN¥28.52